Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 ...

In separate treatment trials, one for de novo coronary lesions and the other for in-stent restenosis, a sirolimus-eluting ...

A Japanese registry study reveals how DanGer shock criteria predict survival in heart attack patients treated with Impella.

SAN FRANCISCO -- The investigational Selution drug-coated balloon (DCB or DEB) edged closer to primetime in percutaneous ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...

Boston Scientific also reported findings from the ALLIANCE registry looking at 1,800 Agent patients in Japan. It assessed the ...

A leading heart doctor has warned that looking 'shredded' on the outside doesn't guarantee good health after treating young, ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB ...

Elixir Medical today announced new landmark clinical results for its DynamX bioadaptor coronary implant system.

People who sleep with lights on face a 47% higher chance of having a heart attack compared to those who keep their nights ...

Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025 DynamX® bioadaptor is the first interventional technology to ...